Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall

Non-vitamin K oral anticoagulant (NOAC) therapy may be inappropriate if prescription was incorrect, the patient’s physiological parameters change, or interacting concomitant medications are erroneously added. The aim of this report was to illustrate inappropriate NOAC prescription in a 78-year-old w...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Flavio Egger, Federica Targa, Ivan Unterholzner, Russell P. Grant, Markus Herrmann, Christian J. Wiedermann
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	MDPI AG 2016-08-01
Reeks:	Clinics and Practice
Onderwerpen:	Direct oral anticoagulants therapeutic drug monitoring drug safety drug-drug interaction pharmacovigilance anticoagulant reversal
Online toegang:	https://www.clinicsandpractice.org/index.php/cp/article/view/873

Gelijkaardige items

Warfarin interactions: a letter to editor
door: Sayyed Majid Sadrzadeh, et al.
Gepubliceerd in: (2019-10-01)

Case report: Medical cannabis—warfarin drug-drug interaction
door: Tyan F. Thomas, et al.
Gepubliceerd in: (2022-01-01)

A rare case of Diffuse Alveolar Hemorrhage (DAH) due to warfarin toxicity
door: Borjian Solmaz, et al.
Gepubliceerd in: (2020-03-01)

Advances in Monitoring and Reversal Strategies for the Novel Anticoagulants Factor Ⅺ Inhibitors
door: CHEN Yuexiu, YAO Yuanyuan, SUN Dawei, WANG Ying, WU Chaomin, ZHAO Linqian, TANG Zhifeng, ZHANG Fengjiang
Gepubliceerd in: (2025-01-01)

Warfarin-Induced Limb Contusion and Haematoma
door: Soumya, et al.
Gepubliceerd in: (2023-04-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
door: Juliana Souto Teles, et al.
Gepubliceerd in: (2012-03-01)

Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report)
door: N. T. Vatutin, et al.
Gepubliceerd in: (2020-03-01)

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report
door: Gumbis G, et al.
Gepubliceerd in: (2023-10-01)

Applied Nanotechnologies in Anticoagulant Therapy: From Anticoagulants to Coagulation Test Performance of Drug Delivery Systems
door: Yuri B. G. Patriota, et al.
Gepubliceerd in: (2021-05-01)

Possible interaction of warfarin with peppermint herbal tea: a case report
door: Aliasghar Moeinipour, et al.
Gepubliceerd in: (2017-05-01)

The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
door: Salih Kılıç, et al.
Gepubliceerd in: (2019-01-01)

Anticoagulation Drug Therapy: A Review
door: Harter, Katherine, et al.
Gepubliceerd in: (2015-01-01)

Warfarin: pharmacological profile and drug interactions with antidepressants
door: Juliana Souto Teles, et al.
Gepubliceerd in: (2012-03-01)

Effects of sodium ferulate for injection on anticoagulation of warfarin in rats in vivo
door: Yue Zhao, et al.
Gepubliceerd in: (2024-02-01)

Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
door: T. Jared Bunch, et al.
Gepubliceerd in: (2016-07-01)

Research progress of antithrombotic drugs
door: ZHANG Jie, MA Xuzhou, LI Huihui, WANG Miao
Gepubliceerd in: (2023-01-01)

Assessing the link between rivaroxaban concentration and the onset of renal impairment in elderly patients: A retrospective observational study
door: Motakatla Usha Rani, et al.
Gepubliceerd in: (2024-06-01)

An Assessment of Osteoporotic Conditions among Users and Non-Users of Warfarin: A Case-Control Study
door: Aseel Hadi Abdulameer, et al.
Gepubliceerd in: (2017-03-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
door: O. V. Shatalova, et al.
Gepubliceerd in: (2015-09-01)

ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS
door: O. V. Shatalova, et al.
Gepubliceerd in: (2015-09-01)

Idiosyncratic Liver Injury due to Rivaroxaban
door: Aneesh Cherakulam Ratheendran, et al.
Gepubliceerd in: (2017-12-01)

Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System
door: Ana Sofia Martins, et al.
Gepubliceerd in: (2024-10-01)

Profile and outcome of patients with Warfarin Toxicity admitted in a tertiary care hospital in Bhutan: a cross-sectional study investigators and institutions
door: Yeshey Penjore, et al.
Gepubliceerd in: (2023-05-01)

Bleeding complications following intramuscular injections among hospitalized anticoagulated patients: a retrospective observational comparative study
door: Marina Davidov, et al.
Gepubliceerd in: (2024-10-01)

Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?
door: Simeon Schietzel, et al.
Gepubliceerd in: (2024-10-01)

Assessment of prescribing pattern and adverse drug reaction in patients receiving anticoagulant therapy: A prospective observational study
door: Thangavel Mahalingam Vijayakumar, et al.
Gepubliceerd in: (2023-08-01)

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
door: Ki Won Hwang, et al.
Gepubliceerd in: (2023-04-01)

Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
door: Takafumi Yuki, MD, PhD, et al.
Gepubliceerd in: (2017-01-01)

Interaction between Levothyroxine and Phenprocoumon: a case report
door: Gaeti Walderez, et al.
Gepubliceerd in: (2014-04-01)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
door: Brandon K. Martinez, et al.
Gepubliceerd in: (2018-04-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
door: S. K. Zyryanov, et al.
Gepubliceerd in: (2020-05-01)

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
door: Anne-Laure Sennesael, et al.
Gepubliceerd in: (2018-11-01)

Advancing anticoagulation stewardship: A call to action for stewardship from the US-based anticoagulation forum
door: Allison Burnett, et al.
Gepubliceerd in: (2022-12-01)

Potential drug-drug interactions among patients with spontaneous intracerebral hemorrhage treated at the Neurological Intensive Care Unit: a single-center experience
door: Dejan Z. Aleksić, et al.
Gepubliceerd in: (2022-11-01)

Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017
door: Josipa Bukic, et al.
Gepubliceerd in: (2019-10-01)

Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia–reperfusion injury
door: Sinan Demirtas, et al.
Gepubliceerd in: (2015-03-01)

Assessing the Comparative Efficacy and Safety of Warfarin and Rivaroxaban for Cancer Associated Thrombosis: Experience From a Resource Limited Setting
door: Abel Tenaw Tasamma, et al.
Gepubliceerd in: (2025-01-01)

Anticoagulants - The Past, The Present, The Future - A Systematic Review
door: Klaudia Warzycka, et al.
Gepubliceerd in: (2024-05-01)

Pharmacological analysis and remote monitoring of a patient with skin ulcers caused by anticoagulation
door: Wu Ling, et al.
Gepubliceerd in: (2023-12-01)

Association between direct oral anticoagulant concentrations and clinical outcomes: A systematic review and meta-analysis
door: Brandon Stretton, et al.
Gepubliceerd in: (2023-12-01)